Table 2 List of the 35 miRNAs used to classify patients into SVR and non-SVR groups using Monte Carlo Cross Validation (MCCV)

hsa-miR-122a

1.32

6.67E-02

1

98.78

889

hsa-miR-21

1.19

3.62E-01

2

94.67

852

hsa-miR-22

1.23

7.80E-02

3

93.22

839

hsa-let-7a

1.14

3.57E-01

4

92.33

831

hsa-miR-23b

1.41

1.72E-02

5

91.44

823

hsa-miR-26a

1.32

7.45E-02

6

90.78

817

hsa-let-7f

1.15

4.04E-01

7

88.67

798

hsa-miR-142-3p

1.39

1.45E-01

8

87.33

786

hsa-miR-494

2.18

5.85E-03

9

82.00

738

hsa-miR-194

1.22

1.70E-01

10

80.78

727

hsa-let-7b

1.11

3.59E-01

11

80.22

722

hsa-miR-148a

1.25

2.28E-01

12

79.67

717

hsa-miR-29a

1.16

2.73E-01

13

77.78

700

hsa-miR-125b

1.20

2.37E-01

14

73.11

658

hsa-miR-192

1.09

4.89E-01

15

69.67

627

hsa-miR-24

1.25

8.31E-02

16

68.89

620

hsa-miR-768-3p

1.19

1.78E-01

17

68.78

619

hsa-miR-126

1.07

6.75E-01

18

49.56

446

hsa-miR-19b

1.15

2.98E-01

19

48.89

440

hsa-miR-370

2.00

1.44E-02

20

39.00

351

hsa-miR-29c

1.26

1.37E-01

21

38.89

350

hsa-miR-16

1.24

2.08E-01

22

37.11

334

hsa-miR-145

1.01

9.25E-01

23

34.89

314

hsa-let-7c

1.21

1.41E-01

24

33.22

299

hsa-miR-215

1.20

3.65E-01

25

27.67

249

hsa-let-7g

1.16

3.64E-01

26

27.44

247

hsa-miR-451

1.13

6.94E-01

27

23.11

208

hsa-miR-26b

1.30

2.26E-01

28

22.22

200

hsa-miR-92

1.12

3.44E-01

29

21.11

190

hsa-miR-29b

1.19

2.62E-01

30

19.44

175

hsa-miR-107

1.21

1.58E-01

31

18.78

169

hsa-miR-27b

1.40

2.32E-02

32

18.11

163

hsa-miR-638

1.32

5.57E-02

33

16.89

152

hsa-miR-199a*

1.12

5.92E-01

34

16.78

151

hsa-miR-193b

1.25

7.24E-02

35

16.67

150